Conformation, Recognition by High Mobility Group Domain Proteins, and Nucleotide Excision Repair of DNA Intrastrand Cross-links of Novel Antitumor Trinuclear Platinum Complex BBR3464

Journal of Biological Chemistry

Volumn 276, Issue 25, 2001, Pages 22191-22199

  Zehnulova, Jana ^a   Kasparkova, Jana ^a   Farrell, Nicholas ^b   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CONFORMATIONS; CROSSLINKING; DNA; DRUG PRODUCTS; PROTEINS;

PLATINUM DRUGS;

BIOCHEMISTRY;

ANTINEOPLASTIC AGENT; BBR 3464; CISPLATIN; DNA; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP B PROTEIN; HIGH MOBILITY GROUP PROTEIN; OLIGONUCLEOTIDE; PLATINUM COMPLEX;

ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPLEX FORMATION; CROSS LINKING; DNA REPAIR; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; EXCISION REPAIR; HUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; BINDING SITE; CHEMISTRY; CONFORMATION; DNA ADDUCT; DRUG EFFECT; METABOLISM; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; BINDING SITES; DNA; DNA ADDUCTS; DNA REPAIR; HIGH MOBILITY GROUP PROTEINS; MOLECULAR PROBES; NUCLEIC ACID CONFORMATION; ORGANOPLATINUM COMPOUNDS;

EID: 0035933825     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M103118200     Document Type: Article

References (74)

1. Farrell, N. (2000) in Platinum-based Drugs in Cancer Therapy (Kelland, L. R., and Farrell, N. P., eds) pp. 321-338, Humana Press Inc., Totawa, NJ
2. Farrell, N., Qu, Y., Bierbach, U., Valsecchi, M., and Menta, E. (1999) in Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert, B., ed) pp. 479-496, Wiley-VCH, Weinheim, Germany
3. Qu, Y., Rauter, H., Fontes, A. P. S., Bandarage, R., Kelland, L. R., and Farrell, N. (2000) J. Med. Chem. 43, 3189-3192
4. Calvert, P. M., Highley, M. S., Hughes, A. N., Plummer, E. R., Azzabi, A. S. T., Verrill, M. W., Camboni, M. G., Verdi, E., Bernareggi, A., Zuchetti, M., Robinson, A. M., Carmichael, J., and Calvert, A. H. (1999) Clin. Cancer Res. 5, 3796s
5. Sessa, C., Capri, G., Gianni, L., Peccatori, F., Grasselli, G., Bauer, J., Zucchetti, M., Vigano, L., Gatti, A., Minoia, C., Liati, P., VandenBosch, S., Bernareggi, A., Camboni, G., and Marsoni, S. (2000) Ann. Oncol. 11, 977-983
6. Rosenberg, B. (1999) in Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert, B., ed) pp. 3-30, Wiley-VCH, Weinheim, Germany
7. Wong, E., and Giandomenico, C. M. (1999) Chem. Rev. 99, 2451-2466
8. O'Dwyer, P. J., Stevenson, J. P., and Johnson, S. W. (1999) in Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert, B., ed) pp. 31-72, Wiley-VCH, Weinheim, Germany
9. O'Dwyer, P. J., Stevenson, J. P., and Johnson, S. W. (2000) Drugs 59, 19-27
10. Perego, P., Caserini, C., Gatti, L., Carenini, N., Romanelli, S., Supino, R., Colangelo, D., Viano, I., Leone, R., Spinelli, S., Pezzoni, G., Manzotti, C., Farrell, N., and Zunino, F. (1999) Mol. Pharmacol. 55, 528-534
11. Pratesi, G., Perego, P., Polizzi, D., Righetti, S. C., Supino, R., Caserini, C., Manzotti, C., Giuliani, F. C., Pezzoni, G., Tognella, S., Spinelli, S., Farrell, N., and Zunino, F. (1999) British J. Cancer 80, 1912-1919
12. Janus, F., Albrechtsen, N., Dornreiter, I., Wiesmüller, L., Grosse, F., and Deppert, W. (1999) Cell. Mol. Life Sci. 66, 12-27
13. Johnson, N. P., Butour, J.-L., Villani, G., Wimmer, F. L., Defais, M., Pierson, V., and Brabec, V. (1989) Prog. Clin. Biochem. Med. 10, 1-24
14. Brabec, V., Kasparkova, J., Vrana, O., Novakova, O., Cox, J. W., Qu, Y., and Farrell, N. (1999) Biochemistry 38, 6781-6790
15. Zaludova, R., Zakovska, A., Kasparkova, J., Balcarova, Z., Kleinwachter, V., Vrana, O., Farrell, N., and Brabec, V. (1997) Eur. J. Biochem. 246, 508-517
16. Perego, P., Gatti, L., Caserini, C., Supino, R., Colangelo, D., Leone, R., Spinelli, S., Farrell, N., and Zunino, F. (1999) J. Inorg. Biochem. 77, 59-64
17. Roberts, J. D., Beggiolin, G., Manzotti, C., Piazzoni, L., and Farrell, N. (1999) J. Inorg. Biochem. 77, 47-50
18. Roberts, J. D., Peroutka, J., and Farrell, N. (1999) J. Inorg. Biochem. 77, 51-57
19. Kloster, M. B. G., Hannis, J. C., Muddiman, D. C., and Farrell, N. (1999) Biochemistry 38, 14731-14737
20. Jamieson, E. R., and Lippard, S. J. (1999) Chem. Rev. 99, 2467-2498
21. Marrot, L., and Leng, M. (1989) Biochemistry 28, 1454-1461
22. Schwartz, A., Marrot, L., and Leng, M. (1989) Biochemistry 28, 7975-7978
23. Bellon, S. F., and Lippard, S. J. (1990) Biophys. Chem. 35, 179-188
24. Bellon, S. F., Coleman, J. H., and Lippard, S. J. (1991) Biochemistry 30, 8026-8035
25. Teuben, J. M., Bauer, C., Wang, A. H. J., and Reedijk, J. (1999) Biochemistry 38, 12305-12312
26. Anin, M. F., and Leng, M. (1990) Nucleic Acids Res. 18, 4395-4400
27. Zlatanova, J., Yaneva, J., and Leuba, S. H. (1998) FASEB J. 12, 791-799
28. Ohndorf, U. M., Rould, M. A., He, Q., Pabo, C. O., and Lippard, S. J. (1999) Nature 399, 708-712
29. Zamble, D. B., and Lippard, S. J. (1999) in Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert, B., ed) pp. 73-110, Wiley-VCH, Weinheim, Germany
30. Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A., and Lippard, S. J. (1996) Biochemistry 35, 10004-10013
31. Reardon, J. T., Vaisman, A., Chaney, S. G., and Sancar, A. (1999) Cancer Res. 59, 3968-3971
32. Moggs, J. G., Szymkowski, D. E., Yamada, M., Karran, P., and Wood, R. D. (1997) Nucleic Acids Res. 25, 480-490
33. Brabec, V., Reedijk, J., and Leng, M. (1992) Biochemistry 31, 12397-12402
34. Stros, M. (1998) J. Biol. Chem. 273, 10355-10361
35. Brabec, V., and Leng, M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5345-5349
36. Comess, K. M., Costello, C. E., and Lippard, S. J. (1990) Biochemistry 29, 2102-2110
37. Lemaire, M., Thauvette, L., Deforesta, B., Viel, A., Beauregard, G., and Potier, M. (1990) Biochem. J. 267, 431-439
38. Maxam, A. M., and Gilbert, W. (1980) Methods Enzymol. 65, 499-560
39. Brabec, V., Sip, M., and Leng, M. (1993) Biochemistry 32, 11676-11681
40. Bailly, C., Gentle, D., Hamy, F., Purcell, M., and Waring, M. J. (1994) Biochem. J. 300, 165-173
41. Ross, S. A., and Burrows, C. J. (1996) Nucleic Acids Res. 24, 5062-5063
42. Bailly, C., and Waring, M. J. (1997) in Drug-DNA Interaction Protocols (Fox, K. R., ed) pp. 51-79, Humana Press Inc, Totowa, NJ
43. Koo, H. S., Wu, H. M., and Crothers, D. M. (1986) Nature 320, 501-506
44. Matsunaga, T., Mu, D., Park, C.-H., Reardon, J. T., and Sancar, A. (1995) J. Biol. Chem. 270, 20862-20869
45. Buschta-Hedayat, N., Buterin, T., Hess, M. T., Missura, M., and Naegeli, H. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 6090-6095
46. Manley, J. L., Fire, A., Cano, A., Sharp, P. A., and Gefter, M. L. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 3855-3859
47. Lemaire, M. A., Schwartz, A., Rahmouni, A. R., and Leng, M. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1982-1985
48. Nielsen, P. E. (1990) J. Mol. Recognit. 3, 1-24
49. McCarthy, J. G., Williams, L. D., and Rich, A. (1990) Biochemistry 29, 6071-6081
50. McCarthy, J. G., and Rich, A. (1991) Nucleic Acids Res. 19, 3421-3429
51. Herr, W. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 8009-8013
52. Johnston, B. H., and Rich, A. (1985) Cell 42, 713-724
53. Koo, H. S., and Crothers, D. M. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 1763-1767
54. Rice, J. A., Crothers, D. M., Pinto, A. L., and Lippard, S. J. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 4158-4161
55. Leng, M. (1990) Biophys. Chem. 35, 155-163
56. Huang, H. F., Zhu, L. M., Reid, B. R., Drobny, G. P., and Hopkins, P. B. (1995) Science 270, 1842-1845
57. Kasparkova, J., and Brabec, V. (1995) Biochemistry 34, 12379-12387
58. Cohen, S. M., Mikata, Y., He, Q., and Lippard, S. J. (2000) Biochemistry 39, 11771-11776
59. He, Q., Ohndorf, U.-A., and Lippard, S. J. (2000) Biochemistry 39, 14426-14435
60. Sancar, A. (1996) Annu. Rev. Biochem. 65, 43-81
61. Wood, R. D. (1996)Annu. Rev. Biochem. 65, 135-167
62. Naegeli, H. (1997) Mechanisms of DNA Damage Recognition in Mammalian Cells, Springer Verlag, New York
63. Reardon, J. T., and Sancar, A. (1998) in Advances in DNA Damage and Repair (Dizdaroglu, M., and Karakaya, A., eds) pp. 377-393, Plenum Publishing Corp., New York
64. Jones, S. L., Hickson, I. D., Harris, A. L., and Harnett, P. R. (1994) Int. J. Cancer 59, 388-393
65. Koberle, B., Masters, J. R. W., Hartley, J. A., and Wood, R. D. (1999) Curr. Biol. 9, 273-276
66. Li, M. J., and Yang, L. Y. (1999) Int. J. Oncol. 15, 1177-1183
67. Huang, J.-C., Svoboda, D. L., Reardon, J. T., and Sancar, A. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3664-3668
68. Kasparkova, J., Farrell, N., and Brabec, V. (2000) J. Biol. Chem. 275, 15789-15798
69. Kasparkova, J., Mellish, K. J., Qu, Y., Brabec, V., and Farrell, N. (1996) Biochemistry 35, 16705-16713
70. Cox, J. W., Berners-Price, S., Davies, M. S., Qu, Y., and Farrell, N. (2001) J. Am. Chem. Soc. 123, 1316-1326
71. McA'Nulty, M., and Lippard, S. J. (1995) Nucleic Acids Mol. Biol. 9, 264-284
72. Whitehead, J. P., and Lippard, S. J. (1996) in Metal Ions in Biological Systems (Sigel, A., and Sigel, H., eds) Vol. 32, pp. 687-726, Marcel Dekker, Inc., New York
73. He, Q., Liang, C. H., and Lippard, S. J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 5768-5772
74. Brabec, V. (2000) in Platinum-based Drugs in Cancer Therapy (Kelland, L. R., and Farrell, N. P., eds) pp. 37-61, Humana Press Inc, Totowa, NJ